Wexford Capital LP Astrazeneca PLC Transaction History
Wexford Capital LP
- $569 Million
- Q4 2024
A detailed history of Wexford Capital LP transactions in Astrazeneca PLC stock. As of the latest transaction made, Wexford Capital LP holds 3,605 shares of AZN stock, worth $266,012. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,605
Previous 3,605
-0.0%
Holding current value
$266,012
Previous $280,000
15.71%
% of portfolio
0.04%
Previous 0.07%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,368Shares Held
475MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.45 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.03 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.77 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.44 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $229B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...